Metabolism of 5-hydroxyicosatetraenoate by human neutrophils: production of a novel omega-oxidized derivative. J Immunol 1986 Nov 15;137(10):3277-83
Date
11/15/1986Pubmed ID
3095426Scopus ID
2-s2.0-0023037584 (requires institutional sign-in at Scopus site) 35 CitationsAbstract
Human neutrophils incorporated 5-hydroxy-E,Z,Z,Z-6,8,11,14-eicosatetraenoic acid (5-HETE) into cellular triglyceride and phospholipid. They also metabolized 5-HETE into a novel, extracellularly released derivative, 5,20-dihydroxy-E,Z,Z,Z-6,8,11,14-eicosatetraenoic acid (5,20-diHETE). 5,20-diHETE formation predominated at higher substrate concentrations and longer incubation intervals. In the absence of added 5-HETE, 1 X 10(8) neutrophils stimulated with 20 microM ionophore A23187 produced up to 243 ng of 5,20-diHETE, indicating that both endogenously formed and exogenously added substrate could be oxidized at carbon 20. 5,20-diHETE was about 10- to 100-fold weaker than 5-HETE in enhancing human neutrophil degranulation responses to platelet-activating factor. omega-Oxidation appears to be a general enzymatic mechanism for inactivation of arachidonic acid metabolites.
Author List
O'Flaherty JT, Wykle RL, Redman J, Samuel M, Thomas MAuthor
Michael J. Thomas PhD Professor in the Pharmacology and Toxicology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
CalcimycinGlucuronidase
Humans
Hydroxyeicosatetraenoic Acids
Muramidase
Neutrophils
Oxidation-Reduction
Phospholipids
Platelet Activating Factor
Spectrum Analysis
Triglycerides